← Back to Search

Behavioral Intervention

NEW FED TR for Anorexia Nervosa (NEW FED TR Trial)

N/A
Waitlist Available
Led By Christina Wierenga, PhD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Current diagnosis of anorexia nervosa
Be between 18 and 65 years old
Must not have
Current suicidal thoughts
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post-treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new treatment for adults with anorexia nervosa that uses brain science to guide intensive therapy sessions involving the patient's family.

Who is the study for?
This trial is for adults who have been diagnosed with anorexia or anorexia nervosa at least two years ago and are medically stable. They must also have a carer willing to join them in treatment. People with current suicidal thoughts, recent substance abuse, developmental disorders, or severe psychiatric conditions like psychosis or bipolar disorder cannot participate.
What is being tested?
The study is testing NEW FED TR, which is a neurobiologically-informed intensive family-based treatment program designed specifically for adults suffering from anorexia nervosa.
What are the potential side effects?
Since this trial involves a skill-based program rather than medication, side effects may include emotional distress or discomfort during therapy sessions as participants work through their eating disorder challenges.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with anorexia nervosa.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am experiencing thoughts of harming myself.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post-treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Eating Disorder Examination Total Score

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: NEW FED TR for AnorexiaExperimental Treatment1 Intervention
NEW FED TR

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Neurobiologically-guided intensive family-based treatment for Anorexia Nervosa leverages insights into the brain's role in the disorder and the critical influence of family dynamics. This approach targets the neurobiological underpinnings of Anorexia Nervosa, such as dysregulated reward processing and heightened anxiety responses, by involving family members in the treatment process. Family members are educated about the neurobiological aspects of the disorder and trained to support the patient through structured meal support and emotional regulation strategies. This method is crucial as it addresses both the biological and environmental factors contributing to Anorexia Nervosa, promoting a more holistic and supportive recovery environment.

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,177 Previous Clinical Trials
1,573,440 Total Patients Enrolled
18 Trials studying Anorexia Nervosa
1,705 Patients Enrolled for Anorexia Nervosa
National Eating Disorders AssociationOTHER
4 Previous Clinical Trials
159 Total Patients Enrolled
1 Trials studying Anorexia Nervosa
72 Patients Enrolled for Anorexia Nervosa
Laura Hill, PhDStudy ChairThe Center for Balanced Living

Media Library

NEW FED TR (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT02852538 — N/A
Anorexia Nervosa Research Study Groups: NEW FED TR for Anorexia
Anorexia Nervosa Clinical Trial 2023: NEW FED TR Highlights & Side Effects. Trial Name: NCT02852538 — N/A
NEW FED TR (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02852538 — N/A
Anorexia Nervosa Patient Testimony for trial: Trial Name: NCT02852538 — N/A
~35 spots leftby Jan 2027